Echo screening for RHD among school children aids timely detection and treatment
Rheumatic heart disease (RHD) causes more than 10 million disability-adjusted life-years every year, accounting for most deaths from valvular heart disease worldwide. In a recent study, researchers have found that early detection of clinically silent rheumatic heart disease and timely initiation of secondary antibiotic prophylaxis is an effective approach to control rheumatic heart disease in endemic regions. The research has been published in the JAMA Cardiology on January 20, 2021.
The burden of RHD is disproportionately prevalent in marginalized communities across sub-Saharan Africa, South Asia, and the Pacific Islands, where endemic patterns of disease prevail. A previous cross-sectional study using echocardiographic screening for RHD in Nepal found that 10 per 1000 children had evidence of RHD with 4 of 5 cases being latent. Early detection of subclinical stages of RHD and timely initiation of secondary antibiotic prophylaxis for the latent disease may reverse subclinical valvular lesions, prevent disease progression, and contain the reservoir for further spread. There is, however, no randomized evidence available to support this notion. Therefore, researchers conducted a study to investigate the effectiveness of systematic echocardiographic screening in combination with secondary antibiotic prophylaxis on the prevalence of rheumatic heart disease.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.